| Detected | Trial | Change |
|---|---|---|
| 2026-08-15 | NCT07123961 Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial |
critical Recruitment suspended |
| 2026-08-15 | NCT07123961 Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial |
critical Recruitment suspended: Suspended for review and amendments to study documents. |
| 2026-08-15 | NCT06693778 Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care… |
Primary endpoint(s) modified |
| 2026-08-15 | NCT06693778 Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care… |
date change Primary completion pushed: 2026-07 -> 2027-03 |
| 2026-08-15 | NCT06693778 Utilizing Electronic Clinical Decision Support to Enhance mTBI Care at the Primary Care… |
date change Completion pushed: 2026-09 -> 2027-09 |
| 2026-08-06 | NCT04891640 Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile… |
Trial completed |
| 2026-08-06 | NCT04891640 Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile… |
Phase changed: not applicable -> Phase 4 |
| 2026-08-06 | NCT04891640 Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile… |
date change Primary completion moved earlier: 2026-07-01 -> 2026-06-01 |
| 2026-08-06 | NCT04891640 Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile… |
date change Completion moved earlier: 2026-07-01 -> 2026-06-01 |
| 2026-08-06 | NCT06440408 Calculating Wall Shear Stress in Infant Pulmonary Veins |
date change Primary completion pushed: 2026-09 -> 2027-06 |
| 2026-08-06 | NCT06440408 Calculating Wall Shear Stress in Infant Pulmonary Veins |
date change Completion pushed: 2027-03 -> 2028-06 |
| 2026-07-22 | NCT01050855 Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders |
Trial completed |
| 2026-07-22 | NCT01050855 Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders |
Enrollment reduced: 75 -> 56 participants |
| 2026-07-22 | NCT01050855 Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders |
Trial arms changed: 3 -> 1 |
| 2026-07-22 | NCT01050855 Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders |
date change Completion moved earlier: 2026-12 -> 2025-06 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-22 | NCT07718802 Observational Approach Versus Surgical Intervention for Stones | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT03490929 | CEUS for Blunt Abdominal Trauma in Children | Trauma Abdomen | Recruiting |
| NCT03473249 | Effectiveness of Contrast-Enhanced Ultrasound | Abdominal Injuries | Active, Not Recruiting |
| Phase 2 | |||
| NCT05783323 | Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer | Differentiated Thyroid Cancer | Recruiting |
| NCT05194397 | Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors | Lymphoblastic Leukemia | Recruiting |
| NCT03301038 | Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria | Idiopathic Infantile Hypercalcaemia - Severe Form | Recruiting |
| NCT06458036 | Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) | Differentiated Thyroid Cancer | Recruiting |
| NCT06693752 | CEUS Evaluation of Hydrocephalus in Neonates and Infants | Hydrocephalus in Infants | Recruiting |
| NCT02323867 | Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic… | Leukemia | Active, Not Recruiting |
| NCT02990819 | Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary… | Immunodeficiencies | Active, Not Recruiting |
| NCT07543822 | 24VA022; VATCH Alpelisib for TIE2/PIK3CA Pathway VAs | Vascular Anomalies | Active, Not Recruiting |
| NCT07549646 | 24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs | Ras/MAPK Pathway Vascular Anomalies | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT05918640 | Lurbinectedin in FET-Fused Tumors | Ewing Sarcoma | Recruiting |
| NCT06364774 | ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia | Beta-Thalassemia | Recruiting |
| NCT06839456 | Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post… | Leukemia | Recruiting |
| NCT04156893 | RH Genotype Matched RBC Transfusions | Sickle Cells Disease | Recruiting |
| NCT06839976 | CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus | SLE | Recruiting |
| Phase 1 | |||
| NCT05569122 | Applying pGz in Mitochondrial Disease | Mitochondrial Myopathies | Recruiting |
| NCT06156410 | Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas | Ewing Sarcoma | Recruiting |
| NCT06819683 | Validation of Nanosensor Oxygen Measurement | MItochondrial Myopathies | Recruiting |
| NCT04086329 | Validation of Oxygen Nanosensor in Mitochondrial Myopathy | Mitochondrial Myopathies | Recruiting |
| NCT07084129 | Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention | Sepsis | Recruiting |
| NCT06440408 | Calculating Wall Shear Stress in Infant Pulmonary Veins | Pulmonary Vein Stenosis | Recruiting |
| Early Phase 1 | |||
| NCT05553041 | 18F-Fluciclovine PET-MRI in High-grade Glioma | Glioma | Recruiting |
| NCT02356653 | Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC | Leukemia | Recruiting |
| NCT03107520 | Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of… | Developmental Dysplasia of the Hip | Recruiting |